News | European Medicines Agency (EMA)
EMA Management Board: highlights of October 2024 meeting. Board elects new vice-chair and endorses draft network strategy to 2028 for public consultation. 4 October 2024. Corporate Governance.
What's new - European Medicines Agency (EMA)
What’s new. Find all new and updated information published on our website in one place below. Filters are available to narrow results down based on your interests, such as whether it relates to human or veterinary medicines or specific topics. This overview covers up to two months back. Current month Previous month Two months ago.
News and events | European Medicines Agency (EMA)
The European Medicines Agency's news announcements, information on meetings and events, public consultations and related information.
European Medicines Agency (EMA)
Featured news and updated for European Academics and researchers in the field of medicine development. The European Medicines Agency is a decentralised agency of the European Union responsible for the evaluation, supervision and safety monitoring of medicines.
COVID-19: latest updates (archive) - European Medicines Agency …
EMA published updated information for COVID-19 Vaccine Valneva, with an increase in its approved shelf life. COVID-19 Vaccine (inactivated, adjuvanted) Valneva. 15/02/2023. The video recording is available of EMA's latest COVID-19 and …
Human medicines: highlights of 2022 | European Medicines …
Feb 16, 2023 · Public health emergencies remained a key priority for EMA in 2022. The highlights document summarises the most important recommendations on vaccines and treatments for COVID-19 and for mpox (monkeypox).
EMA publishes annual report 2021
Jun 10, 2022 · EMA’s annual report 2021 published today provides an overview of the Agency’s activities to protect and promote public and animal health in the European Union (EU) and highlights EMA’s most significant achievements.
Meeting highlights from the - European Medicines Agency (EMA)
Feb 22, 2024 · EMA’s human medicines committee (CHMP) recommended 10 medicines for approval at its February 2024 meeting. The committee adopted positive opinions for two vaccines intended for active immunisation against the H5N1 subtype of influenza A virus, also refered to as avian influenza or bird flu.
Newsletters - European Medicines Agency (EMA)
The European Medicines Agency (EMA) publishes newsletters to provide updates on various topics to patients, healthcare professionals and the pharmaceutical industry.
Press and social media | European Medicines Agency (EMA)
The European Medicines Agency's (EMA) press office deals with enquiries from media on matters relating to the work of the Agency. EMA also manages a number of social-media platforms to raise awareness about its work on public and animal health …